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Abstract
BACKGROUND: Preeclampsia, chronic arterial hypertension is one of the causes of maternal and perinatal 
morbidity and mortality.
AIM: The aim of our study was to assess the level of extracellular nucleic acids in red blood cells and blood plasma 
in pregnant women with severe preeclampsia, severe chronic hypertension, and pregnant women with chronic 
hypertension with superimposed preeclampsia.
METHODS: A total of 107 pregnant women were examined who were hospitalized at the Regional Clinical Hospital 
and at the Regional Perinatal Center in Karaganda and 29 healthy non-pregnant women. Pregnant women were 
divided into four groups: 1 group – 32 pregnant with severe chronic hypertension, 2 group – 48 pregnant women 
with severe preeclampsia, 3 group – 35 women entered the group with chronic hypertension with superimposed 
preeclampsia, and group control – 29 healthy non-pregnant women of child bearing age (4th group – control).
RESULTS: The content of ecNA in the erythrocytes of pregnant women with chronic hypertension with superimposed 
preeclampsia sharply increases relative to the control and comparison groups; in pregnant women with severe 
hypertension and severe preeclampsia, the level of ecNA is moderately higher relative to the control, but lower than 
in the main group.
CONCLUSION: Our data indicate significant changes in the level of ecNA in pregnant women with various types of 
hypertension and require further research, but now, changes in the concentration of ecNA can be considered as one 
of the links in the pathogenesis of preeclampsia.
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Introduction
Various types of hypertension are occurred 
during pregnancy: Preeclampsia, chronic arterial 
hypertension, chronic hypertension with superimposed 
preeclampsia, and gestational hypertension [1], [2], [3]. 
Preeclampsia and chronic arterial hypertension are 
one of the reasons of maternal and perinatal morbidity 
and mortality [2], [4], [5], [6]. The prevalence rate of 
preeclampsia in the world is 2.7–8.2% [3], [4], [5], [6]. 
Percentage of maternal mortality, caused by diseases 
of circulatory system, is 29.8 [7]. Preventive activities 
have low efficiency, and screening tools are not always 
specific, treatment is aimed at eliminating obvious clinical 
manifestations. The only effective treatment of these 
conditions is delivery [8], [9]. Thus, this complication of 
pregnancy remains a serious problem for doctors.
Preeclampsia is a heterogeneous disorder, 
triggered by several different underlying mechanisms. 
There are more than 30 theories of the development 
of preeclampsia [8], [9], [10], [11]. One of the leading is 
the theory of endothelial dysfunction [12] and placental 
theory [9]. Violation of trophoblast invasion leads to 
decrease in oxygenation and, accordingly, to the formation 
of oxidative stress. Microvasculature’s damage in organs 
and tissues leads to oxidative stress and accumulation 
of reactive oxygen species (ROS). The result of lipid 
and protein peroxidation, activation of membrane 
phospholipases, mechanical (osmotic) stretching, and 
adsorption of foreign proteins are destruction of cells’ 
structural and functional properties [8], [9], [11].
At present, extracellular nucleic acids (ecNA) 
have a great interest [13], [14], [15], [16].
Extracellular nucleic acids can exist in free 
form or can be absorbed on blood cells or as a part 
of vesicles [15], [16], [17], [18]. Usually, the amount 
of circulating DNA is very low in healthy people. The 
growth of circulating DNA is observed in patients with 
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certain types of cancer process [19], [20], [21], [22], in 
pregnant women [23], [24].
Extracellular DNA in the blood plasma of 
pregnant women is used as an additional criterion for 
prenatal diagnosis of determining the Rh-factor, the 
sex of the fetus, and determining the risk of premature 
birth [24], [25], [26]. A single study in the literature 
reports that an increasing of extracellular DNA in 
the first trimester of pregnancy is connected with the 
development of preeclampsia [27]. However, there 
are no data on the state of ecNA in the second and 
third trimester in pregnant women with hypertensive 
disorders.
One of the reasons of the growth of 
extracellular DNA is considered of violation of the 
invasion of chorionic villi. The literature describes data 
on the placental nucleic acids [27], [28], [29], [30], [31]. 
A higher concentration of extracellular placental DNA 
is associated with pregnancy complications and a 
higher risk of fetal rejection. It is still not clear whether 
higher concentrations of extracellular nucleic acids 
in maternal circulation cause or result from various 
complications.
A hypothesis has been proposed that oxidative 
damage of DNA occurs under conditions of oxidative 
stress. Fragments of oxidized DNA are released from 
the nuclei of cells and act as a stress signal. Oxidized 
DNA can be reason of ROS’s formation, which triggers 
an adaptive response, including changes in gene 
expression of antioxidant defense and detoxification 
enzymes and the formation of stress actin filaments [32].
Extracellular RNA can be released from cells 
both by the formation of vesicles and in combination 
with proteins that protect them from the effects of 
endonucleases. It is believed that RNA protected 
by vesicles or proteins can perform the function of 
intercellular communicators [33].
The literature describes single study of ecNA 
in pregnant women with preeclampsia in pregnancy 
or with arterial hypertension [29]; however, there are 
no studies regarding to ecNA content in pregnant 
women suffering from chronic hypertension with 
superimposed preeclampsia. To date, there is a 
high incidence of such a combined pathology, 
which is clinically characterized by increased blood 
pressure, the appearance of proteinuria (0.3 g/l or 
more) in urinalysis, the possible development of 
complications such as intrauterine growth retardation, 
placental abruption, cerebrovascular accident, more 
often hemorrhagic type, and other complications of 
preeclampsia and hypertension [1], [2], [9]. Thus, the 
clinical and pathogenetic significance of extracellular 
nucleic acids in the mother’s blood with chronic 
hypertension with superimposed preeclampsia 
remains poorly studied, as well as their role in the 
pathogenesis of this pathology.
The purpose of the study
In this regard, the aim of our study was to 
assess the level of extracellular nucleic acids in red 
blood cells and blood plasma in pregnant women with 
severe preeclampsia, severe chronic hypertension, and 
pregnant women suffered from chronic hypertension 
with superimposed preeclampsia.
Materials and Methods
A total of 107 pregnant women were 
hospitalized at the Regional Clinical Hospital and at the 
Regional Perinatal Center in Karaganda and 29 healthy 
non-pregnant women. The criterion for the inclusion of 
pregnant women in the study was the informed consent 
of the woman to participate in the study and gestational 
age between 20 and 42 weeks. The age of patients 
ranged from 18 to 48 years (mean age – 28.66 years). 
The age of pregnant women are younger than 25 years- 
15.3%, 26–30 years –38.1%, 36–40 years –60.6%, 
41–48 years –7.2%. It was found that the prevalence 
of hypertension is high in the groups of patients 26–30 
and 36–40 years old. The exclusion criteria were cancer 
diseases, HIV infection, tuberculosis, concomitant 
severe somatic pathology, obesity, mental illness, and 
drug addiction. The study design was approved by the 
ethics committee of the Karaganda Medical University 
(No. 33, 03/01/2018). Pregnant women were divided 
into three groups and group control:
•	 Group 1 – 32 pregnant with severe chronic 
hypertension
•	 Group 2 – 48 pregnant women with severe 
preeclampsia
•	 Group 3 – 35 women entered the group with 
chronic hypertension with superimposed 
preeclampsia
•	 Group control – 29 healthy non-pregnant 
women of childbearing age (Group 4 – control).
We have taken non-pregnant women as a 
control because the literature data report that there are 
no significant differences in the level of extracellular 
nucleic acids in the blood of healthy pregnant and non-
pregnant women. Hence, in the work of Ershova et al., 
there were no significant differences in the content of 
extracellular (cell free) nucleic acids (both average and 
median) in the blood of healthy pregnant women and 
non-pregnant women [34].
The diagnosis of severe preeclampsia, severe 
arterial hypertension, and chronic hypertension with 
superimposed preeclampsia has made on the basis of 
the classification proposed by the protocol of diagnosis 
and treatment of the Ministry of Health of the Republic of 
Kazakhstan “Arterial hypertension in pregnant women” 
No. 36 dated December 27, 2017 (based on ICD-10), 
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with a systolic blood pressure (SBP) ≥160 mmHg 
and/or diastolic blood pressure (DBP) ≥110 mmHg. 
Severe preeclampsia was diagnosed in pregnant 
women based on an increase in SBP ≥160 mmHg and/
or DBP ≥110 mmHg with proteinuria 0.3 g/l and more 
in the single portion of urine or proteinuria in the daily 
urine 0.3 g and more. Pregnant women with HELLP 
syndrome and eclampsia are excluded from the study.
Blood was the material of the study. It was 
stabilized by heparin. A blood test has been performed no 
later than an hour after blood sampling. The acid-soluble 
fraction (ASF) of nucleic acid precursors, extracellular 
RNA, and DNA in plasma was evaluated by the method 
of Markusheva et al. [33]. The unit of measurement 
is μg/ml. The principle of quantitative determination 
of ASF, RNA, and DNA consisted of the extraction of 
nucleic acids after hydrolysis carried out at various 
temperatures in a water bath, followed by centrifugation 
for 15 min at 3000 r/pm and spectrophotometry of ASF, 
RNA, and DNA hydrolysates [33].
Results
The results have processed by statistical methods: 
Descriptive statistics (median, upper, lower quartile, and 
reliability were determined using dispersion analysis – non-
parametric Kruskal–Wallis test, pairwise non-parametric 
Mann–Whitney U-test). The results are presented in 
Tables 1 and 2.
From the data, Table 1 follows that the 
content of ecNA in plasma and red blood cells has a 
multidirectional change in indicators.
The highest ecNA values in the blood 
erythrocytes were found in pregnant women of the third 
(main) group: A significant increase in ASF by 8 times, 
RNA by 5 times, and DNA by 4 times relative to the 
control group at p < 0.013 (by median). In Groups 1 and 
2 of pregnant women, there was a trend to increase 
the level of ecNA relative to control. A significant 
increase in the level of ecNA in the main group relative 
to comparison groups by more than 3 times is also 
determined.
In plasma, a significant increase in ecNA was 
also observed in the main group of pregnant women 
with respect to the control: An increase in ASF, RNA, 
and DNA by 3 times relative to the control group 
with p < 0.013 (by median). The ecNA’s level of the 
comparison groups was also higher relative to the 
control by 2 times. The level of RNA and DNA in the 
main group was 1.5–2.0 times higher relative to the 
comparison groups (by median), while the ASF level 
was the highest in the blood plasma of Group 2 relative 
to the control. There was a tendency toward an increase 
in plasma levels of RNA and DNA of pregnant women 
with severe preeclampsia relative to pregnant women 
with severe chronic hypertension.
As a result of the study, it was found that the 
content of ecNA in pregnant women with various types 
of hypertension significantly increased relative to the 
control. Thus, the content of ecNA in the erythrocytes 
of pregnant women with chronic hypertension with 
superimposed preeclampsia sharply increases relative 
to the control and comparison groups. The level of ecNA 
in pregnant women with severe chronic hypertension 
and severe preeclampsia is moderately higher relative 
to the control, but lower than in the main group. A 
similar picture is also observed in the blood plasma; 
however, the severity of differences relative to control 
is lower than in the red blood cells, and the dynamic 
of plasma ASF in the main group differs significantly 
compared to comparison groups. Thus, as a result 
of the study, ecNA of pregnant women with chronic 
hypertension with superimposed preeclampsia is more 
associated with red blood cells. The binding of ecNA 
to erythrocytes leads to destabilization of erythrocyte 
membranes, loss of elasticity of red blood cell, and 
resistance to shear stress decreases. Such red blood 
cells die prematurely in the bloodstream, releasing 
procoagulant coagulation factors, and also contribute to 
the development of oxidative stress. In addition, ecNA 
binding to erythrocytes affects to the transport function 
of red cell membranes, thereby leading to a change of 
the osmotic resistance of red blood cells, as well as 
Table 1: Extracellular nucleic acids in the red blood cells
Groups ASF in erythrocytes 
Median Q25 Q75
RNA in erythrocytes Median 
Q25 Q75
DNA in erythrocytes 
Median Q25 Q75
1 Severe arterial hypertension (comparison group) 0.0063* (0.0228; 0.0036) 0.0093* (0.0264; 0.0035) 0.0235* (0.0450; 0.0175)
2 Severe preeclampsia (comparison group) 0.0065* (0.0193; 0.0049) 0.0049 (0.0171; 0.0023) 0.0234* (0.0361; 0.0186)
3 Chronic hypertension with superimposed preeclampsia (the main group) 0.0257* (0.0369; 0.0217) 0.0216*# (0.0274; 0.0100) 0.0393*% (0.0498; 0.0341)
Control 0.0032 (0.0043; 0.0016) 0.0038 (0.0059; 0.0012) 0.0089 (0.0117; 0.0038)
*Significant differences between 1, 2, and 3 of ASF and the control P<0.013. *Significant differences between Groups 1 and 3 of RNA and the control. *Significant difference between Groups 1, 2, and 3 of DNA and the 
control. #Significantly differences between Groups 2 and 3 of RNA. %Significant difference between 1 group of DNA and 3 group of DNA. ASF: Acid-soluble fraction.
Table 2: Extracellular nucleic acids in the plasma
Groups ASF in plasma Median (Q25 Q75) RNA in plasma Median (Q25, Q75) DNA in plasma Median (Q25, Q75)
1 Severe arterial hypertension (comparison group) 0.0172* (0.0234; 0.0128) 0.0053% (0.0063; 0.0037) 0.0041 (0.0086; 0.0023)
2 Severe preeclampsia (comparison group) 0.0240* (0.0347; 0.0158) 0.0071* (0.0143; 0.0057) 0.0072* (0.0217; 0.0053)
3 Chronic hypertension with superimposed preeclampsia (main group) 0.0190* (0.0500; 0.0136) 0.0118*& (0.0247; 0.0057) 0.0107*^ (0.0327; 0.0086)
Control 0.0116 (0.0178; 0.0025) 0.0043 (0.0055; 0.0038) 0.0047 (0.0052; 0.0038)
*Significant difference between 1, 2, and 3 groups of ASF and control P<0.013.*Significant difference between the 2 and 3 RNA groups and the control. *Significant difference between the 2 and 3 groups of DNA and the 
control. &Significant difference between the 3rd and 1st RNA groups among themselves. %Significant difference between Groups 1 and 2 of RNA. ^Significant difference between the 3 and 1 groups of DNA. ASF: Acid-soluble 
fraction.
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inhibiting the transport of hemoglobin and subsequent 
complete gas exchange, which ultimately leads to 
hypoxia, oxidative stress. Furthermore, ecNA binding 
to erythrocytes can be transformed into microvesicles, 
the significance and function of which remains poorly 
understood to date [18].
Circulation of ecNA in plasma in a large quantity 
affects to the rheological properties of blood. More 
likely, long-circulating ecNA in plasma can activate the 
blood coagulation system, which leads to the chronic 
disseminated intravascular coagulation syndrome, 
which is one of the pathogenetic mechanisms of 
gestosis. It is still not clear whether higher concentrations 
of ecNA in maternal circulation cause or result from 
various complications. It can be assumed that a high 
level of ecNA in a group of pregnant women with such 
pathology as a chronic hypertension with superimposed 
preeclampsia is more likely to be associated with the 
potentiating effect of both nosologies on the target 
organs – kidneys, hemostasis system. It can be 
assumed that the level of ecNA in pregnant women with 
chronic hypertension with superimposed preeclampsia 
is probably due to the maternal part of ecNA; however, 
a number of studies need to be conducted to answer 
this question.
Clinical application of ecNA research 
demonstrates prospects for further studies of 
extracellular nucleic acids to determine their 
participation in the mechanisms of development and 
progression of kidney damage in pregnant women with 
chronic hypertension with superimposed preeclampsia. 
As a future perspective, the continuation of the study 
of the ecNA will probably allow it to be used as a target 
treatment. Extracellular RNA activates contact phase 
of coagulation. Extracellular RNA’s growth indicates 
enhanced coagulation and supports mechanisms of 
gestosis. Thus, it can be used for determining of disease 
progression; however, further research is needed.
Conclusion
Thus, our data indicate significant changes in 
the level of ecNA in pregnant women with various types 
of hypertension and require further research; however, 
changes in the concentration of ecNA can be considered 
as one of the links in the pathogenesis of preeclampsia. 
In addition, it is necessary to study ecNA and 
simultaneously study extracellular vesicles, which may 
also contain ecNA (platelet’s, leukocyte’s, erythrocyte’s 
vesicles, as well as endothelial vesicles) [18]. At present, 
the only treatment of preeclampsia, as well as severe 
chronic hypertension, is delivery. Premature delivery 
often leads to high neonatal mortality and morbidity. 
Thus, it is necessary to continue the study of ecNA, 
extracellular vesicles, and their complex interactions 
to further understand the initiation and progression of 
a hypertensive state of pregnancy. This result shows 
perspectives of ecNA’s profound investigation to 
determine their role in gestosis’ development. 
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